ASTH
Astrana Health, Inc. NASDAQ Listed Mar 11, 2009$39.17
+2.65%
vs $38.16
Mkt Cap $1.9B
52w Low $18.16
96.9% of range
52w High $39.85
50d MA $35.96
200d MA $28.28
P/E (TTM)
85.2x
EV/EBITDA
20.1x
P/B
3.4x
Debt/Equity
1.4x
ROE
2.9%
P/FCF
18.5x
RSI (14)
60.70
ATR (14)
$1.48
Beta
0.77
50d MA
$35.96
200d MA
$28.28
Avg Volume
509.6K
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
1668 S. Garfield Avenue · Alhambra, CA 91801 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | 0.29 | 0.29 | +0.0% | 36.08 | +2.3% | +8.9% | -3.4% | +2.7% | +1.9% | -1.5% | — |
| Mar 2, 2026 | AMC | 0.15 | 0.54 | +260.0% | 26.32 | -1.9% | -6.9% | +4.4% | -2.0% | -0.6% | -0.8% | — |
| Nov 6, 2025 | AMC | 0.47 | 0.01 | -97.9% | 33.36 | -7.1% | -23.4% | -12.2% | +6.1% | -1.0% | -7.0% | — |
| Aug 7, 2025 | AMC | 0.36 | 0.19 | -47.2% | 21.46 | +11.8% | +30.8% | +2.2% | +1.4% | +1.8% | -0.3% | — |
| May 8, 2025 | AMC | 0.23 | 0.14 | -39.1% | 33.44 | -4.0% | -11.2% | -3.9% | -6.4% | -0.7% | +2.1% | — |
| Feb 27, 2025 | AMC | 0.22 | -0.15 | -168.2% | 34.68 | -10.0% | -26.8% | +4.3% | +1.1% | +1.5% | +0.1% | — |
| Nov 7, 2024 | AMC | 0.32 | 0.33 | +3.1% | 59.08 | -2.8% | -20.5% | -0.3% | -8.3% | -2.3% | -0.0% | — |
| Aug 7, 2024 | AMC | 0.39 | 0.40 | +2.6% | 46.36 | +11.8% | +1.1% | +2.3% | -2.4% | +2.0% | -2.3% | — |
| May 7, 2024 | AMC | 0.30 | 0.31 | +3.3% | 37.93 | -2.5% | +0.4% | +2.5% | -0.4% | +0.7% | +2.2% | — |
| Feb 27, 2024 | AMC | 0.15 | 0.26 | +73.3% | 43.54 | +1.9% | +0.5% | +2.9% | -3.3% | +0.9% | -1.7% | — |
| Nov 7, 2023 | AMC | 0.27 | 0.47 | +74.1% | 29.39 | +7.2% | +9.1% | -5.0% | -0.8% | +3.8% | +8.8% | — |
| Jun 30, 2023 | AMC | 0.25 | 0.28 | +13.0% | 31.60 | -0.4% | -1.8% | -1.4% | -2.4% | +3.0% | +4.3% | — |
| Mar 31, 2023 | AMC | 0.31 | 0.28 | -8.8% | 36.47 | +0.2% | +3.4% | +2.9% | -1.3% | -0.3% | +2.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26 | Barclays | Upgrade | Equal Weight → Overweight | $50 | $37.85 | $38.98 | +3.0% | +1.8% | -0.1% | -0.5% | -1.9% | +0.4% |
| Apr 15 | Baird | Maintains | Outperform → Outperform | — | $29.07 | $29.45 | +1.3% | +0.6% | +4.7% | +2.9% | -0.2% | +3.5% |
| Mar 13 | Truist | Maintains | Buy → Buy | — | $23.25 | $23.91 | +2.8% | +4.3% | +1.4% | +0.8% | -1.3% | -1.3% |
| Feb 2 | BTIG | Maintains | Buy → Buy | — | $22.74 | $22.41 | -1.5% | -1.8% | -4.7% | +3.5% | -1.5% | -2.8% |
| Nov 25 | Jefferies | Maintains | Buy → Buy | — | $22.60 | $22.84 | +1.1% | +2.7% | -0.7% | -0.0% | +0.6% | -1.6% |
| Nov 24 | Barclays | Maintains | Equal Weight → Equal Weight | — | $22.50 | $21.96 | -2.4% | +0.4% | +2.7% | -0.7% | -0.0% | +0.6% |
| Nov 10 | TD Cowen | Maintains | Buy → Buy | — | $25.54 | $25.55 | +0.0% | -12.2% | +6.1% | -1.0% | -7.0% | -1.7% |
| Nov 7 | BTIG | Maintains | Buy → Buy | — | $33.36 | $31.00 | -7.1% | -23.4% | -12.2% | +6.1% | -1.0% | -7.0% |
| Mar 18 | Truist | Maintains | Buy → Buy | — | $30.60 | $30.29 | -1.0% | +4.7% | -1.6% | -2.2% | +0.2% | +3.2% |
| Mar 4 | BofA Securities | Maintains | Buy → Buy | — | $26.48 | $26.50 | +0.1% | +1.1% | +1.5% | +0.1% | +8.0% | -1.9% |
| Mar 3 | Baird | Maintains | Outperform → Outperform | — | $25.38 | $25.55 | +0.7% | +4.3% | +1.1% | +1.5% | +0.1% | +8.0% |
| Feb 20 | Stifel | Maintains | Buy → Buy | — | $39.09 | $39.03 | -0.2% | -4.3% | -4.6% | -3.1% | +2.3% | -0.8% |
| Jan 13 | Truist | Maintains | Buy → Buy | — | $29.48 | $29.08 | -1.4% | +2.7% | +3.0% | +0.5% | +6.4% | +5.4% |
| Nov 13 | Baird | Maintains | Outperform → Outperform | — | $42.91 | $44.86 | +4.5% | -2.3% | -0.0% | -2.6% | -0.7% | +1.0% |
| Oct 3 | BTIG | Maintains | Buy → Buy | — | $57.87 | $58.06 | +0.3% | +2.8% | +0.7% | -1.0% | -0.7% | -1.0% |
| Aug 15 | Baird | Maintains | Outperform → Outperform | — | $46.58 | $47.90 | +2.8% | +2.4% | +1.1% | -0.8% | -1.3% | +2.2% |
| Aug 9 | Truist | Maintains | Buy → Buy | — | $46.85 | $47.08 | +0.5% | +2.3% | -2.4% | +2.0% | -2.3% | +2.4% |
| Aug 1 | Stifel | Maintains | Buy → Buy | — | $52.46 | $53.00 | +1.0% | -1.7% | -4.4% | -4.3% | +0.8% | -2.6% |
| Jul 11 | Truist | Upgrade | Hold → Buy | — | $38.20 | $40.03 | +4.8% | +17.8% | +4.9% | +0.8% | +7.1% | -0.3% |
| Jun 27 | Stifel | Maintains | Buy → Buy | — | $40.03 | $40.64 | +1.5% | +1.8% | -0.5% | -2.0% | +0.4% | +0.1% |
| May 8 | Stifel | Maintains | Buy → Buy | — | $37.93 | $37.00 | -2.5% | +0.4% | +2.5% | -0.4% | +0.7% | +2.2% |
| Mar 1 | Truist | Maintains | Hold → Hold | — | $45.04 | $45.00 | -0.1% | -3.3% | +0.9% | -1.7% | +1.4% | +2.0% |
| Feb 22 | BofA Securities | Upgrade | Neutral → Buy | — | $38.75 | $40.43 | +4.3% | +7.6% | -2.1% | +4.8% | +1.8% | +0.5% |
| Feb 27 | Lake Street | Maintains | Buy → Buy | — | $35.44 | $35.93 | +1.4% | -0.5% | -1.0% | +4.6% | +3.7% | +0.4% |
| Aug 8 | Barclays | Maintains | Equal Weight → Equal Weight | — | $54.40 | $55.07 | +1.2% | -2.7% | -4.5% | +1.1% | -3.3% | +0.4% |
No insider trades available.
8-K · 5.02
!!! Very High
Astrana Health, Inc. -- 8-K 5.02: Executive Change
Jun 10
8-K · 5.02
!!! Very High
Astrana Health, Inc. -- 8-K 5.02: Executive Change
May 12
8-K · 7.01
! Medium
Astrana Health, Inc. -- 8-K 7.01: Regulation FD Disclosure
May 12
8-K · 2.02
!! High
Astrana Health, Inc. -- 8-K 2.02: Earnings Results
Astrana Health reported earnings results in an 8-K filing, with detailed financial performance metrics available in the attached press release exhibit for investor review.
May 7
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
ASTH completed a material acquisition, and investors should review the acquired business's financial performance in the filing to assess whether the deal enhances earnings and strategic positioning.
Mar 30
8-K · 7.01
! Medium
Astrana Health Inc. -- 8-K 7.01: Regulation FD Disclosure
Astrana Health disclosed corporate presentation slides via 8-K filing, though the company disclaims any obligation to update the information provided to investors.
Mar 4
NT 10-K
!!! Very High
Astrana Health Inc. -- Late Annual Report -- Distress Signal
Astrana Health's delayed annual report signals integration challenges from recent acquisitions may impact financial transparency and investor confidence in management's operational efficiency.
Mar 2
8-K · 8.01
!! High
Astrana Health Inc. -- 8-K 8.01: Material Event / Announcement
Astrana Health doubled its share repurchase authorization to $100 million, signaling management confidence and providing flexibility to return capital to shareholders through various purchase methods.
Mar 2
8-K · 5.02
!!! Very High
Black Hawk Acquisition Corporation Class A -- 8-K 5.02: Executive Change
Black Hawk Acquisition Corp appointed Mitchell Creem as CFO and Frederick Woodruff Field as director, strengthening management ahead of potential merger completion or operational transition.
Feb 3
Institutional (13F) — Top 0
All ↗
No 13F holders found.
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.93B
Enterprise Value
$2.50B
P/E (TTM)
85.15x
Forward P/E
31.61x
PEG Ratio
-1.09x
P/B
3.44x
P/S
0.61x
P/FCF
18.51x
EV/EBITDA
20.08x
Shares Out
49.4M
Financials (TTM)
Revenue
$3.18B
Net Income
$22.5M
EBITDA
$124.3M
Free Cash Flow
$104.5M
Op Cash Flow
$114.6M
EPS Basic
$0.46
EPS Diluted
$0.46
EPS Forward
$1.24
Gross Margin
9.3%
Op Margin
2.5%
Net Margin
0.7%
Balance Sheet
Total Assets
$2.22B
Total Liab.
$1.66B
Total Equity
$558.3M
Cash
$429.5M
LT Debt
$990.9M
Book Value/Sh
$11.38
Debt/Equity
1.38x
Current Ratio
1.40
Quick Ratio
1.40
Returns & Growth
ROE
2.9%
ROA
1.0%
ROIC
2.9%
Rev Growth YoY
+56.4%
EPS Growth YoY
-49.5%
Price Returns
2W
-3.9%
1M
+10.2%
3M
+85.0%
6M
+63.3%
12M
+51.8%
Technicals
52W High
$39.85
52W Low
$18.16
50d MA
$35.96
200d MA
$28.28
RSI (14)
60.70
ATR (14)
$1.48
Beta
0.77
Avg Volume
510K
Dividends
Div Rate
$0.16
Div Yield
0.5%
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$34.20
High
$40.00
Low
$26.00
Median
$37.00
Data updated apr 24, 2026 7:22pm
· Source: financialmodelingprep.com